Edition:
India

China NT Pharma Group Co Ltd (1011.HK)

1011.HK on Hong Kong Stock

1.83HKD
21 Jun 2018
Change (% chg)

-- (--)
Prev Close
HK$1.83
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
5,557,265
52-wk High
HK$2.48
52-wk Low
HK$1.61

Chart for

About

China NT Pharma Group is a China-based company principally engaged in the research and development, production and sales of pharmaceuticals. The Company mainly conducts its businesses through three segments. The Proprietary Product Production and Sales segment is engaged in the production and sales of NT branded products and... (more)
No analyst recommendations are available for .

Overall

Beta: 0.86
Market Cap(Mil.): HK$3,148.32
Shares Outstanding(Mil.): 1,558.58
Dividend: 0.03
Yield (%): 1.24

Financials

  1011.HK Industry Sector
P/E (TTM): 18.48 20.98 40.93
EPS (TTM): 0.11 -- --
ROI: 11.58 11.71 62.11
ROE: 12.60 13.91 73.68

BRIEF-Pfenex And NT Pharma Enter Into A Development And License Agreement For Pfenex's PF708 Therapeutic Equivalent Candidate To Forteo

* PFENEX AND NT PHARMA ENTER INTO A DEVELOPMENT AND LICENSE AGREEMENT FOR PFENEX'S PF708 THERAPEUTIC EQUIVALENT CANDIDATE TO FORTEO®

19 Apr 2018

BRIEF-China NT Pharma Group Co Appoints Wang Fei As CFO

* ‍APPOINTS WANG FEI AS CFO Source text for Eikon: Further company coverage:

06 Apr 2018

BRIEF-China Nt Pharma Group Co ‍Fy Net Profit Attributable RMB 165.2 Mln VS RMB 116.2 Mln​

* ‍FY NET PROFIT ATTRIBUTABLE RMB165.2 MILLION VERSUS RMB116.2 MILLION​

27 Mar 2018

Earnings vs. Estimates